First Tracks Biotherapeutics, Inc. (TRAX) has 7 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 4, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 4, 2026 filed Sept. 2, 2026 | Ware J. Anthony Director | $1,532,764 | 117,795 | — | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 15, 2026 | Lizzul Paul F. Chief Medical Officer | $0 | 60,492 | 0% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 15, 2026 | STONE BENJAMIN Chief Business Officer | $0 | 60,492 | 0% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 15, 2026 | Faga Daniel President, CEO | $0 | 193,575 | 0% | No | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 2, 2026 | STONE BENJAMIN Chief Business Officer | $0 | 60,492 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free